JW Pharmaceutical Corp (001060):企業の財務・戦略的SWOT分析

◆英語タイトル:JW Pharmaceutical Corp (001060) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15130
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
JW Pharmaceutical Corp (JW Pharmaceutical), a subsidiary of JW Holdings Corp is a provider of generic drugs. The company develops and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, and others. It offers multivitamins and antianemic agents, contact lens care and ophthalmic agents, antifungal agents, cardiovascular agents, and gastrointestinla agents. JW Pharmaceutical also offers topicals, amino acid solutions, flexible IV container, IV solutions, respiratory agents, obgy agents, nephrology agents, CNS, urology agents and diabetic agents. The company offers products for cardiovascular, gastrointestinal, nephrology or antianaemic, anticancer and neuropsychiatry. It operates through its production and manufacturing facilities in South Korea. JW Pharmaceutical is headquartered in Seoul, South Korea.

JW Pharmaceutical Corp Key Recent Developments

Oct 29,2018: JW Pharmaceutical invests in British anti-cancer drugs developer
Aug 28,2018: LEO Pharma to develop and commercialise JW Pharmaceutical’s JW1601

This comprehensive SWOT profile of JW Pharmaceutical Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of JW Pharmaceutical Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

JW Pharmaceutical Corp – Key Information
JW Pharmaceutical Corp – Overview
JW Pharmaceutical Corp – Key Employees
JW Pharmaceutical Corp – Key Employee Biographies
JW Pharmaceutical Corp – Key Operational Heads
JW Pharmaceutical Corp – Major Products and Services
JW Pharmaceutical Corp – History
JW Pharmaceutical Corp – Company Statement
JW Pharmaceutical Corp – Locations And Subsidiaries
JW Pharmaceutical Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

JW Pharmaceutical Corp – Business Description
JW Pharmaceutical Corp – Corporate Strategy
JW Pharmaceutical Corp – SWOT Analysis
SWOT Analysis – Overview
JW Pharmaceutical Corp – Strengths
JW Pharmaceutical Corp – Weaknesses
JW Pharmaceutical Corp – Opportunities
JW Pharmaceutical Corp – Threats
JW Pharmaceutical Corp – Key Competitors

Section 3 – Company Financial Performance Charts

JW Pharmaceutical Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

JW Pharmaceutical Corp, Key Information
JW Pharmaceutical Corp, Key Ratios
JW Pharmaceutical Corp, Share Data
JW Pharmaceutical Corp, Major Products and Services
JW Pharmaceutical Corp, History
JW Pharmaceutical Corp, Key Employees
JW Pharmaceutical Corp, Key Employee Biographies
JW Pharmaceutical Corp, Key Operational Heads
JW Pharmaceutical Corp, Other Locations
JW Pharmaceutical Corp, Subsidiaries
JW Pharmaceutical Corp, Key Manufacturing facilities
JW Pharmaceutical Corp, Key Competitors
JW Pharmaceutical Corp, SWOT Analysis
JW Pharmaceutical Corp, Ratios based on current share price
JW Pharmaceutical Corp, Annual Ratios
JW Pharmaceutical Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

JW Pharmaceutical Corp, Performance Chart
JW Pharmaceutical Corp, Ratio Charts

★海外企業調査レポート[JW Pharmaceutical Corp (001060):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sensorion SA (ALSEN):企業の財務・戦略的SWOT分析
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …
  • Nautilus Marine Services Plc (NAUT):石油・ガス:M&Aディール及び事業提携情報
    Summary Nautilus Marine Services Plc (Nautilus Marine Services), formerly Global Energy Development PLC is an oil and gas company that offers petroleum production and oil and gas exploration and development services. The company’s services include production, drilling, and exploration of properties, …
  • Massachusetts General Hospital-医療機器分野:企業M&A・提携分析
    Summary Massachusetts General Hospital (MGH) is a healthcare service provider which offers diagnostic and therapeutic care services. The hospital provides services such as allergy and immunology; ALS multidisciplinary clinic, anesthesia, critical care and pain medicine; back bay healthcare center, b …
  • Immunicom Inc:医療機器:M&Aディール及び事業提携情報
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company that develops non-pharmaceutical therapies for oncology and autoimmune diseases. The company offers immune inhibitors that play a key role in protecting tumors from the body’s natural immune mechanisms. It proprietary Immunophere …
  • EnCana Corporation:戦略・SWOT・企業財務分析
    EnCana Corporation - Strategy, SWOT and Corporate Finance Report Summary EnCana Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Exelon Corp (EXC):企業の財務・戦略的SWOT分析
    Exelon Corp (EXC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hanmi Pharmaceuticals Co Ltd (128940):企業の財務・戦略的SWOT分析
    Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Xencor, Inc.:企業のM&A・事業提携・投資動向
    Xencor, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Xencor, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Allen-Vanguard Corp:企業の戦略・SWOT・財務分析
    Allen-Vanguard Corp - Strategy, SWOT and Corporate Finance Report Summary Allen-Vanguard Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • WEG SA:企業の戦略・SWOT・財務分析
    WEG SA - Strategy, SWOT and Corporate Finance Report Summary WEG SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Koninklijke Philips NV (PHIA):企業の製品パイプライン分析
    Summary Koninklijke Philips NV (Philips) is a diversified technology company that develops and manufactures medical systems and consumer electronics products. The company offers products and solutions in the areas of diagnostic imaging, enterprise diagnostic informatics, image-guided therapy, ultras …
  • Icon Energy Ltd (ICN):企業の財務・戦略的SWOT分析
    Summary Icon Energy Ltd (Icon Energy), formerly Icon Oil NL, is an oil and gas exploration and production company that acquires, explores, and develops oil and gas properties. The company's exploration tenements include ATP 855, PRL's 33-49, ATP 594, ATP 626, ATP 794, ATP 549 West, PEP 170, PEP 172, …
  • Evolution Mining Ltd:企業のM&A・事業提携・投資動向
    Evolution Mining Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evolution Mining Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • PepsiCo Inc:企業のM&A・事業提携・投資動向
    PepsiCo Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PepsiCo Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Capitol Health Ltd (CAJ)-医療機器分野:企業M&A・提携分析
    Summary Capitol Health Ltd (Capitol Health) is a medical device company that provides diagnostic imaging and related services. The company provides services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic re …
  • Cimarex Energy Co (XEC):企業の財務・戦略的SWOT分析
    Cimarex Energy Co (XEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude …
  • Ei Group plc:企業の戦略・SWOT・財務分析
    Ei Group plc - Strategy, SWOT and Corporate Finance Report Summary Ei Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Domtar Corporation:戦略・SWOT・企業財務分析
    Domtar Corporation - Strategy, SWOT and Corporate Finance Report Summary Domtar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • KT Corporation:企業のM&A・事業提携・投資動向
    KT Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KT Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆